882
P. K. DEB ET AL.
ꢂ ꢂ
ꢂ
17. Venugopala KN, Kandeel M, Pillay M, et al. Anti-tubercular
properties of 4-amino-5-(4-fluoro-3- phenoxyphenyl)-4h-
1,2,4-triazole-3-thiol and its schiff bases: Computational
input and molecular dynamics. Antibiotics 2020;9:559.
18. Venugopala KN, Nayak SK, Pillay M, et al. Synthesis and antitu-
bercular activity of 2-(substituted phenyl/benzyl-amino)-6-(4-
chlorophenyl)-5-(methoxycarbonyl)-4-methyl-3,6-dihydropyri-
midin-1-ium chlorides. Chem Biol Drug Des 2013;81:219–27.
19. Venugopala KN, Dharma Rao GB, Bhandary S, et al. Design,
synthesis, and characterization of (1-(4-aryl)- 1h-1,2,3-tria-
zol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-
tetrahydropyrimidine-5-carboxylates against mycobacterium
tuberculosis. Drug Des Dev Ther 2016; 10:2681–90.
20. Venugopala KN, Chandrashekharappa S, Pillay M, et al.
Synthesis and structural elucidation of novel benzothiazole
derivatives as anti-tubercular agents: in-silico screening for
possible target identification. Med Chem 2019;15:311–26.
21. Venugopala KN, Khedr MA, Pillay M, et al. Benzothiazole ana-
logs as potential anti-tb agents: Computational input and
molecular dynamics. J Biomol Struct Dynam 2019;37:1830–42.
22. Venugopala KN, Uppar V, Sandeep C, et al. Cytotoxicity
and antimycobacterial properties of pyrrolo[1,2-a]quinoline
derivatives: molecular target identification and molecular
docking studies. Antibiotics 2020;9:233–14.
23. Venugopala KN, Tratrat C, Pillay M, et al. Anti-tubercular
activity of substituted 7-methyl and 7-formylindolizines
and in silico study for prospective molecular target identifi-
cation. Antibiotics 2019;8:247.
24. Venugopala KN, Chandrashekharappa S, Pillay M, et al.
Computational, crystallographic studies, cytotoxicity and
anti-tubercular activity of substituted 7-methoxy-indolizine
analogues. Plos One 2019;14:e0217270.
25. Salgado-Moran G, Ramirez-Tagle R, Glossman-Mitnik D,
et al. Docking studies of binding of ethambutol to the c-
terminal domain of the arabinosyltransferase from
Mycobacterium tuberculosis. J Chem 2013;2013:1–5.
35. Gobec M, Tomasic T, Markovic T, et al. Antioxidant and
anti-inflammatory properties of 1,2,4-oxadiazole analogs of
resveratrol. Chem-Biol Interact 2015;240:200–7.
36. dos Santos Filho JM, de Lima JG, Leite LFCC. Synthesis,
characterization, and anti-inflammatory evaluation of 1,2,4-
oxadiazoles combined with thiosemicarbazide and 1,3,4-
oxadiazole moieties. J Heterocyclic Chem 2009;46:722–7.
37. Leite LFCC, Ramos MN, da Silva JBP, et al. Synthesis and
analgesic profile of novel n-containing heterocycle deriva-
tives: arylidene 3-phenyl-1,2,4-oxadiazole-5-carbohydrazide.
Il Farmaco 1999;54:747–57.
38. Kayukova LA, Praliev KD, Akhelova AL, et al. Local anesthetic
activity of new amidoxime derivatives. Pharm Chem J 2011;
45:468–71.
39. Shaikh A, Meshram J. Novel 1,3,4-oxadiazole derivatives of
dihydropyrimidinones: Synthesis, anti-inflammatory, anthel-
mintic, and antibacterial activity evaluation. J Heterocyclic
Chem 2016;53:1176–82.
40. Guda DR, Park S-J, Lee M-W, et al. Syntheses and anti-allergic
activity of 2-((bis(trimethylsilyl)methylthio/methylsulfonyl)-
methyl)-5-aryl-1,3,4-oxadiazoles. Eur J Med Chem 2013;62:84–8.
41. Wang M, Liu T, Chen S, et al. Design and synthesis of 3-(4-
pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives
as novel gsk-3b inhibitors and evaluation of their potential
as multifunctional anti-alzheimer agents. Eur J Med Chem
2021;209:112874.
42. Palumbo Piccionello A, Musumeci R, Cocuzza C, et al. Synthesis
and preliminary antibacterial evaluation of linezolid-like 1,2,4-
oxadiazole derivatives. Eur J Med Chem 2012;50:441–8.
43. Rai NP, Narayanaswamy VK, Govender T, Manuprasad BK,
et al. Design, synthesis, characterization, and antibacterial
activity of f5-chloro-2-[(3-substitutedphenyl-1,2,4-oxadiazol-
5-yl)-methoxy]-phenylg-(phenyl)-methanones. Eur
Chem 2010;45:2677–82.
J Med
44. Kumar D, Patel G, Chavers AK, et al. Synthesis of novel
1,2,4-oxadiazoles and analogues as potential anticancer
agents. Eur J Med Chem 2011;46:3085–92.
45. Zhang H-Z, Kasibhatla S, Kuemmerle J, et al. Discovery and
structure-activity relationship of 3-aryl-5-aryl-1,2,4-oxadia-
zoles as a new series of apoptosis inducers and potential
anticancer agents. J Med Chem 2005;48:5215–23.
€
26. Tiemann F, Kruger P. Ueber amidoxime und azoxime. Berichte
Der Deutschen Chemischen Gesellschaft 1884;17:1685–98.
27. Newman H. Photochemistry of 3,5-diphenyl-1,2,4-oxadiazole
ii. Photolysis in protic media. Tetrahedron Lett 1968;9:2421–4.
28. Newman H. Photochemistry of 3,5-diphenyl-1,2,4-oxadiazole i.
Photolysis in aprotic media. Tetrahedron Lett 1968;9:2417–20.
29. Coupar IM, Hedges A, Metcalfe HL, Turner P. Effect of ami-
nophylline, butalamine and imolamine on human isolated
smooth muscle. J Pharm Pharmacol 1969;21:474–5.
46. Vaidya A, Jain S, Prashantha Kumar B, et al. Synthesis of
1,2,4-oxadiazole derivatives: anticancer and 3d qsar studies.
€
Monatshefte fur Chemie - Chem Mon 2020;151:385–95.
47. Lankau H-J, Unverferth K, Grunwald C, et al. New gaba-
modulating 1,2,4-oxadiazole derivatives and their anticon-
vulsant activity. Eur J Med Chem 2007;42:873–9.
30. Rotbart HA, Webster AD. Treatment of potentially life-
threatening enterovirus infections with pleconaril. Clin
Infect Dis 2001;32:228–35.
48. Mohammadi-Khanaposhtani M, Ahangar N, Sobhani S,
et al. Design, synthesis, in vivo, and in silico evaluation of
new coumarin-1,2,4-oxadiazole hybrids as anticonvulsant
agents. Bioorg Chem 2019;89:102989.
31. McDonald CM, Campbell C, Torricelli RE, et al. Ataluren in
patients with nonsense mutation duchenne muscular dys-
trophy (ACT DMD): a multicentre, randomised, double-blind,
placebo-controlled, phase. The Lancet 10101;2017:1489–98.
32. Kesornpun C, Aree T, Mahidol C, et al. Water-assisted nitrile
oxide cycloadditions: synthesis of isoxazoles and stereo-
selective syntheses of isoxazolines and 1, 2, 4-oxadiazoles.
Angewandte Chemie 2016;128:4065–9.
€
€
€
49. Ergun Y, Orhan OF, Ozer UG, Gis¸i G. Synergistic effect of
[1h-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one] and anti-
depressant drugs in the mouse forced swimming test: pos-
sible involvement of serotonergic pathway. Eur
Pharmacol 2010;630:74–8.
50. Sangshetti JN, Shinde DB. Synthesis of some novel 3-(1-(1-
substitutedpiperidin-4-yl)-1h-1,2,3-triazol-4-yl)-5-substituted
phenyl-1,2,4-oxadiazoles as antifungal agents. Eur J Med
Chem 2011;46:1040–4.
J
33. Bogdan AR, Wang Y. A high-throughput synthesis of 1,2,4-
oxadiazole and 1,2,4-triazole libraries in a continuous flow
reactor. RSC Adv 2015;5:79264–9.
ꢁ
34. Biernacki K, Dasko M, Ciupak O, et al. Novel 1,2,4-oxadiazole
51. Abulwerdi FA, Shortridge MD, Sztuba-Solinska J, et al.
Development of small molecules with a noncanonical
derivatives in drug discovery. Pharmaceuticals 2020;13:111.